PASITHEA

With an experienced team of experts in the fields of neuroscience and pharmacology, Pasithea is developing new molecular entities for the treatment of CNS disorders, including Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis, Neurofibromatosis type 1 and Noonan syndrome... We are a biopharmaceutical company dedicated to developing new therapies for the treatment of central nervous system (CNS) diseases... We are a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.

Also known as: Pasithea Therapeutics, Pasithea Therapeutics Corp., Pasithea Therapeutics Limited

Primary location: Miami Beach United States